SENS
Senseonics Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.58
+1.59%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$9.43
From 52W high−15.22%
Volume1.62M
Market cap$506.53M
P/E (TTM)—
P/S (TTM)10.4x
Div yield—
Key dataSep 18, 2026
Open
$9.43
From 52W high
−15.22%
Volume
1.62M
Market cap
$506.53M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.2x
P/E (TTM)
—
RSI (14)
62.5
MomentumView details →
1D Return
+1.59%
YTD Return
+70.38%
Similar companies
Latest newsMore news →
Senseonics Holdings announced a strategic partnership with Beta Bionics to integrate the Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas, with a planned commercial launch in Q4 2026.6d agoSenseonics Holdings reported Q2 2026 revenue of $14.5 million, a 120% increase year-over-year, with a net loss of $36.7 million.46d agoSenseonics (SENS) partners with Welldoc to develop a next-generation Eversense 365 app with Apple Health and Google Health Connect integration ahead of the U.S. launch.101d ago